NCT00134758 - Ursodeoxycholic Acid in the Treatment of Duodenal Adenomas in Familial Adenomatous Polyposis (FAP) Patients | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 31, 2004

Primary Completion Date

June 30, 2009

Study Completion Date

October 31, 2009

Conditions

Adenomatous Polyposis Coli, Familial

Interventions

DRUG

Ursodeoxycholic acid

"During 2 years :~* between 40 and 50 kg : 500 mg/day~* between 51 and 75 kg : 750 mg/day~* between 76 and 100 kg : 1000 mg/day"

DRUG

Placebo

"During 2 years :~* between 40 and 50 kg : 2 tabs/day~* between 51 and 75 kg : 3 tabs/day~* between 76 and 100 kg : 4 tabs/day"

Trial Locations (1)

Saint-Antoine Hospital, Paris